Michael Mollerus

Davis Polk advised the underwriters in connection with the offering of $750 million aggregate principal amount of 2.25% bonds due 2026, issued by the Province of British Columbia. The…

Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Medallion Financial Corp. of $30 million aggregate principal amount of 9.000% notes due…

Davis Polk is advising Markit on its all-share merger of equals with IHS valued at more than $13 billion. The transaction is expected to close in the second half of 2016, subject to…

Davis Polk advised the joint book-running managers on an SEC-registered offering by KKR & Co. L.P. of 13,800,000 6.75% Series A preferred units, which includes the full exercise of the…

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of €1 billion principal amount of its 0.500% notes due 2021, €750…

Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance II B.V., a wholly owned subsidiary of LyondellBasell Industries N.V., of €750…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of €1 billion aggregate principal amount of its floating…

Davis Polk advised the representatives of the several underwriters, on an SEC-registered offering by General Motors Company of $2.0 billion in aggregate principal amount of senior notes,…

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of $900 million principal amount of its floating-rate notes due 2017,…